State Street’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Hold |
|
|||||
|
2025
Q1 | $86K | Sell |
|
|||||
|
2024
Q4 | $104K | Buy |
|
|||||
|
2024
Q3 | $180K | Hold |
|
|||||
|
2024
Q2 | $161K | Sell |
|
|||||
|
2024
Q1 | $889K | Buy |
|
|||||
|
2023
Q4 | $735K | Sell |
|
|||||
|
2023
Q3 | $2.35M | Buy |
|
|||||
|
2023
Q2 | $3.18M | Buy |
|
|||||
|
2023
Q1 | $3.49M | Buy |
|
|||||
|
2022
Q4 | $4.51M | Buy |
|
|||||
|
2022
Q3 | $6.92M | Buy |
|
|||||
|
2022
Q2 | $2.81M | Buy |
|
|||||
|
2022
Q1 | $3.88M | Sell |
|
|||||
|
2021
Q4 | $15.8M | Buy |
|
|||||
|
2021
Q3 | $30.5M | Sell |
|
|||||
|
2021
Q2 | $33.8M | Buy |
|
|||||
|
2021
Q1 | $36.6M | Buy |
|
|||||
|
2020
Q4 | $29M | Buy |
|
|||||
|
2020
Q3 | $6.88M | Buy |
|